share_log

Burcon Charts Path to Revenue Growth in Shareholder Letter

Burcon Charts Path to Revenue Growth in Shareholder Letter

Burcon 在股東信中描繪了收入增長之路
newsfile ·  2023/12/18 20:46

Vancouver, British Columbia--(Newsfile Corp. - December 18, 2023) - Burcon NutraScience Corporation (TSX: BU) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, today issued a letter to shareholders from its Chief Executive Officer, Kip Underwood.

不列顛哥倫比亞省溫哥華--(Newsfile Corp.,2023年12月18日)——食品和飲料植物蛋白開發領域的全球技術領導者Burcon NutraScience Corporation(多倫多證券交易所股票代碼:BU)(“Burcon” 或 “公司”)今天發佈了首席執行官基普·安德伍德致股東的一封信。

Dear shareholders,

親愛的股東們,

Optimism and Confidence in Burcon 2.0

Burcon 2.0 中的樂觀情緒和信心

At my one-year mark as Burcon's CEO, I write to you more optimistic than ever about our future and excited to execute our Burcon 2.0 plan. Burcon's financing in May 2023 enabled us to launch Burcon 2.0, in which we fine-tuned our strategies and business plans. Through a strategic deep dive, we have uncovered additional value in our technologies and identified remarkable opportunities that align with our Burcon 2.0 strategy. We have repositioned the company to focus on our three strategic imperatives, which are to identify additional revenue sources, get closer to customers and gain more influence over the production of our proteins. We remain focused on creating a market-leading plant protein ingredient business, a company that we've always aspired to be.

在我擔任Burcon首席執行官一週年之際,我寫信給你,對我們的未來比以往任何時候都更加樂觀,也很高興能執行我們的Burcon 2.0計劃。Burcon 在 2023 年 5 月的融資使我們得以推出 Burcon 2.0,在其中我們對戰略和業務計劃進行了微調。通過戰略深入研究,我們發現了我們技術的額外價值,並發現了與我們的Burcon 2.0戰略相一致的非凡機遇。我們對公司進行了重新定位,將重點放在三項戰略要務上,即尋找額外的收入來源,拉近與客戶的距離,以及對蛋白質生產獲得更大的影響力。我們仍然專注於創建市場領先的植物蛋白原料業務,這是我們一直渴望成爲的公司。

Having lost, at least temporarily, one of our routes-to-market in Merit, we pivoted to a capital-light business model which affords us speed-to-market. Our hemp launch in July has given us a direct path to revenue. Marketing has yielded promising results, with a number of customers ready-to-purchase and others in late-stage product acceptance. With a signed production agreement with our partner manufacturer, we expect to complete the process validation trials and begin commercial production in early 2024. As Burcon expects to begin generating revenue from hemp sales, we continue to build on our business momentum with initiatives to drive growth and pave the way to profitability.

在Merit至少暫時失去了一條進入市場的途徑之後,我們轉向了輕資本的商業模式,這爲我們提供了進入市場的速度。我們在7月份推出的大麻爲我們提供了直接的收入途徑。營銷取得了令人鼓舞的成果,許多客戶準備購買,而其他客戶則處於後期階段。通過與我們的合作伙伴製造商簽署生產協議,我們預計將在2024年初完成工藝驗證試驗並開始商業化生產。Burcon預計將開始從大麻銷售中獲得收入,因此我們將繼續通過推動增長和爲盈利鋪平道路的舉措來鞏固業務勢頭。

Our sunflower protein technology is promising to be a significant value driver for Burcon. In addition to sunflower's exceptional attributes and clean label health halo, we foresee very favorable long-term economics from our sunflower technology. We anticipate the launch of our unique sunflower proteins, complete with significant market development activities, in 2024. We look forward to the commercialization of our sunflower proteins.

我們的向日葵蛋白技術有望成爲Burcon的重要價值驅動力。除了向日葵的特殊屬性和清潔標籤的健康光環外,我們預計,我們的向日葵技術將帶來非常有利的長期經濟效益。我們預計將在2024年推出我們獨特的向日葵蛋白,並開展重大的市場開發活動。我們期待向日葵蛋白的商業化。

Burcon's pea and canola proteins are commercially proven and are consistently validated by customers as "best-in-class". We have engaged with numerous former customers of Merit who have expressed support for us to bring our products back to market. We are actively exploring various routes to market to bring back these novel proteins, both capital light and the acquisition of production assets. Acquiring production assets is a Go-to-Market strategy that would have the additional benefit of providing the ability to produce our full portfolio of proprietary plant-based proteins.

Burcon 的豌豆和菜籽蛋白已經過商業驗證,並一直被客戶驗證爲 “一流的”。我們已經與Merit的許多前客戶進行了接觸,他們表示支持我們將產品重返市場。我們正在積極探索各種進入市場的途徑,以帶回這些新蛋白,包括資本投資和收購生產資產。收購生產資產是一種進入市場的策略,其額外好處是能夠生產我們全套專有植物基蛋白質。

Our Cash Runway and Forward Outlook

我們的現金跑道和前景展望

I am pleased to share that we have executed an agreement to access the second tranche of the $10 million loan from our largest shareholder. We are sincerely grateful to our largest shareholder for its continued belief and support in Burcon. In addition, we are finalizing an agreement to receive non-dilutive government funding to support our hemp and sunflower commercialization efforts. These sources of non-dilutive funding, taken together with projected sales revenue, are expected to extend Burcon's cash runway and allow us to execute our plan.

我很高興地與大家分享,我們已經簽署了一項協議,從我們的最大股東那裏獲得1000萬美元貸款的第二部分。我們衷心感謝我們的最大股東對Burcon的持續信任和支持。此外,我們正在敲定一項協議,以獲得非稀釋性政府資金,以支持我們的大麻和向日葵商業化工作。這些非稀釋性資金來源,加上預計的銷售收入,預計將擴大Burcon的現金渠道,使我們能夠執行計劃。

Burcon is at an inflection point; on the verge of becoming a revenue generating company. I am confident that we are well positioned on a path towards profitability.

Burcon正處於轉折點;即將成爲一家創收公司。我相信,我們在盈利之路上處於有利地位。

Looking Beyond 2024

展望 2024 年以後

The plant-based food market is ripe for diverse protein choices that are better-for-you and better-for-the-planet. Food and beverage makers continue to seek new protein ingredients to formulate innovative consumer products, ingredients that enable them to meet the challenges of taste and functionality that have, to some extent, stymied earlier efforts. Prominent brands like Pepsico's Muscle Milk and Kraft Heinz's Mac and Cheese have introduced plant-based renditions, demonstrating the demand for sustainable plant-based offerings. The future looks promising for us as we have the products they need.

植物性食品市場的時機已經成熟,有多種蛋白質可供選擇,這些蛋白質對你更有益,對地球也更有益。食品和飲料製造商繼續尋找新的蛋白質原料來配製創新的消費品,這些原料使他們能夠應對口味和功能方面的挑戰,而這些挑戰在某種程度上阻礙了先前的努力。百事可樂的Muscle Milk和卡夫亨氏的Mac and Cheese等知名品牌已經推出了植物基產品,這表明了對可持續植物基產品的需求。因爲我們有他們需要的產品,對我們來說,未來看起來很有希望。

Our aspirations are high as we believe Burcon's new-to-the-world hemp and sunflower proteins offer compelling value propositions and will be able to capture a substantial share of the expanding ingredients market. We are now in a stronger position than a year ago and have developed a solid execution plan that will enable us to drive growth and capitalize on opportunities in front of us. With its portfolio of game-changing technologies, Burcon has the potential to become a market-leading protein ingredients provider and a plan to get there.

我們的抱負很高,因爲我們相信Burcon的新鮮大麻和向日葵蛋白提供了令人信服的價值主張,並將能夠在不斷擴大的原料市場中佔據很大份額。與一年前相比,我們現在處於更有利的地位,並且已經制定了可靠的執行計劃,這將使我們能夠推動增長並利用擺在我們面前的機會。憑藉其改變遊戲規則的技術組合,Burcon有可能成爲市場領先的蛋白質成分供應商,並計劃實現這一目標。

I am proud of our team's resiliency, their dedication this past year and how they embraced change. Our bullish outlook for 2024 marks a significant step in our journey, charting a course towards sustainable growth and profitability for Burcon.

我爲我們團隊的韌性、他們過去一年的奉獻精神以及他們如何接受變革感到自豪。我們對2024年的看漲前景標誌着我們在旅程中邁出了重要的一步,爲Burcon開闢了實現可持續增長和盈利的道路。

In closing, I want to express my gratitude for your support as we turn the page on this challenging year. The Burcon team members are committed to delivering value to Burcon and our shareholders. I truly believe our best days are in front of us and I look forward to leading us there.

最後,在我們翻開這個充滿挑戰的一年之際,我要對你們的支持表示感謝。Burcon 團隊成員致力於爲 Burcon 和我們的股東創造價值。我堅信我們最美好的日子就在我們面前,我期待着帶領我們實現這一目標。

Sincerely,

真誠地,

"Kip Underwood"

“基普·安德伍德”

Kip Underwood

基普·安德伍德

Chief Executive Officer

首席執行官

About Burcon NutraScience Corporation

關於 Burcon NutraScience 公司

Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. Our proteins exhibit superior functionality, taste and nutrition, making them ideal ingredients for food formulators. With over two decades of experience, Burcon has amassed an extensive patent portfolio covering its specialty plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. Burcon is striving to become a vertically integrated provider of specialty plant-based protein solutions that delivers on health, nutrition and sustainability. Supporting the growing trend towards a plant-based diet, Burcon is developing premium protein ingredients that we believe are better for you and better for the planet. For more information, visit burcon.ca.

Burcon 是爲食品和飲料開發植物基蛋白的全球技術領導者。我們的蛋白質具有卓越的功能、口感和營養,使其成爲食品配方設計師的理想原料。憑藉二十多年的經驗,Burcon積累了廣泛的專利組合,涵蓋了其源自豌豆、菜籽油、大豆、大麻和葵花籽以及其他植物來源的特種植物蛋白。Burcon 正努力成爲提供健康、營養和可持續性的特種植物基蛋白解決方案的垂直整合提供商。Burcon支持植物性飲食的增長趨勢,正在開發優質蛋白質成分,我們相信這些成分對您更有益,對地球也有好處。欲了解更多信息,請訪問 burcon.ca。

Forward-Looking Information Cautionary Statement

前瞻性信息警示聲明

The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2023 and its other public filings with Canadian securities regulators on SEDAR+ at . This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.

多倫多證券交易所尚未對本文所含信息內容的充分性進行審查,也不承擔任何責任。本新聞稿包含1995年《美國私人證券訴訟改革法》和適用的加拿大證券立法所指的前瞻性陳述或前瞻性信息。前瞻性陳述或前瞻性信息涉及風險、不確定性和其他因素,這些因素可能導致實際業績、表現、前景和機會與此類前瞻性陳述所表達或暗示的結果存在重大差異。前瞻性陳述或前瞻性信息可以通過諸如 “預期”、“目標”、“打算”、“計劃”、“目標”、“項目”、“估計”、“預期”、“相信”、“未來”、“可能”、“可能”、“將” 等詞語以及對未來時期的類似提法來識別。除歷史事實陳述外,本新聞稿中包含的所有陳述均爲前瞻性陳述。無法保證此類陳述會被證明是準確的,實際結果和未來事件可能與此類聲明或信息中的預期存在重大差異。可能導致實際業績與Burcon的計劃和預期存在重大差異的重要因素包括我們的業務模式和增長戰略的實施;我們行業的趨勢和競爭;我們未來的業務發展、財務狀況和經營業績以及我們以具有成本效益的方式獲得融資的能力;政府法規的潛在變化;以及Burcon不時在向證券監管機構和證券交易所提交的文件(包括本節)中詳述的其他風險和因素Burcon截至2023年3月31日止年度的年度信息表及其在SEDAR+上向加拿大證券監管機構提交的其他公開文件中標題爲 “風險因素”,網址爲。此列表並未詳盡列出可能影響公司任何前瞻性陳述或信息的因素。任何前瞻性陳述或信息僅代表其發表之日,而且,除非適用的證券法另有要求,否則Burcon不承擔任何更新任何前瞻性陳述的意圖或義務,無論是由於新信息、未來事件還是其他原因。儘管伯康認爲前瞻性陳述中固有的假設是合理的,但前瞻性陳述並不能保證未來的表現,因此,投資者不應依賴此類陳述。

Industry and Investor Contact
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca

行業和投資者聯繫人
保羅·林
投資者關係與傳播總監
Burcon NutraScience 公司
電話 (604) 733-0896,免費電話 (888) 408-7960
plam@burcon.ca

Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM

媒體聯繫人:
史蒂夫坎貝爾,APR
主席
坎貝爾公司公共關係
電話 (604) 888-5267
TECH@CCOM-PR.COM

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論